Proctozone-B (bisacodyl) NDC 57237-337

NDC codes

FDA NDC Directory

Product NDC (as listed)57237-337Labeler and product segments. Claims need a package NDC.

Product NDC at billing width57237-0337Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
57237-337-03	57237033703	6 BLISTER PACK in 1 CARTON (57237-337-03) / 5 SUPPOSITORY in 1 BLISTER PACK (57237-337-51)Marketed from Feb 1, 2025
57237-337-21	57237033721	3 BLISTER PACK in 1 CARTON (57237-337-21) / 4 SUPPOSITORY in 1 BLISTER PACK (57237-337-04)Marketed from Dec 1, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Proctozone-B
Generic name (nonproprietary): bisacodyl
Active ingredients: Bisacodyl — 10 mg/1
Dosage form: Suppository
Route: Rectal
Labeler: Rising Pharma Holdings, Inc.
Product type: Over-the-counter drug
Marketing category: OTC monograph drugApplication M007.60
Marketing start: Dec 1, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 57237-337_ad7d1357-40a1-47d3-bb30-77aaf1547659SPL ID ad7d1357-40a1-47d3-bb30-77aaf1547659SPL set ID c53ed934-3846-4dc8-b97b-c84171c21ae1RxCUI 198509UNII 10X0709Y6I
Pharmacologic class: Stimulant Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N457237033703 followed by a unit qualifier and the quantity

Package 57237-0337-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 22, 2024.

Indications (excerpt from the label)

Use for relief of occasional constipation (irregularity) this product generally produces bowel movement in 15 minutes to 1 hour

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under M007.60

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under M007.60
Product	Strength	Form · route	Labeler	Product NDC
Senna Syrupsennosides	Sennosides 8.8 mg/5mL	LiquidOral	Rising Pharma Holdings, Inc.	57237-301
Senna Syrupsennosides	Sennosides 8.8 mg/5mL	LiquidOral	Rising Pharma Holdings, Inc.	57237-310